Geenebaum Cancer Center, University of Maryland Medical Center — Baltimore, Maryland

Geenebaum Cancer Center, University of Maryland Medical Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Geenebaum Cancer Center, University of Maryland Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Dry Eye Disease, oGVHD.

Sponsors: University of Maryland, Baltimore.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Geenebaum Cancer Center, University of Maryland Medical Center?

Geenebaum Cancer Center, University of Maryland Medical Center has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Geenebaum Cancer Center, University of Maryland Medical Center conducted?

Geenebaum Cancer Center, University of Maryland Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Dry Eye Disease, oGVHD.

Is Geenebaum Cancer Center, University of Maryland Medical Center accredited by Crixeo Clinical Trials?

Geenebaum Cancer Center, University of Maryland Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Geenebaum Cancer Center, University of Maryland Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.